DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Licensing - Global Trends: By Industry (Biotech) Mid-Year Review" report has been added to ResearchAndMarkets.com's offering.
This mid-year review report provides comprehensive analysis on all such licensing deals and negotiations that took place between global biotech companies during January 1, 2018 to June 30, 2018, categorized and summarized by various important aspects such as key countries, across key regions, market capitalization groups, medicine groups, licensing payment arrangements, worldwide vs domestic licensing, and R&D vs commercialization licensing.
Such detailed analysis helps to understand the licensing trends and directions during this time period in the global biotech sector.
Key Features
- 6 months' licensing transactions for global biotech sector analyzed at one place
- Small, medium and big multinational/non-multinational companies covered
- Curated categorizations of licensing details
- 8+ variables reflecting different forms of transactions done
- Licensing trends and directions summarized
Key Analysis Provided (January-June 2018)
- Total number of licensing deals signed in the global biotech sector
- Total number of companies/institutes involved in the licensing deals for global biotech sector
- Most licensing deals signed by which country's biotech companies
- Most licensing deals signed by which market capitalization group's biotech companies
- Most licensing deals signed by which medicine groups for global biotech sector
- Licensing payment arrangements most followed in the licensing deals for global biotech sector
- Number of domestic and worldwide licensing in global biotech sector
- Number of R&D and commercialization licensing in global biotech sector
For more information about this report visit https://www.researchandmarkets.com/research/dbrpnf/2018_global?w=4
